NEOFORDEX - Trademark Details
Status: 709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Image for trademark with serial number 79144403
Serial Number
79144403
Registration Number
4705767
Word Mark
NEOFORDEX
Status
709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Status Date
2021-11-26
Filing Date
2014-01-31
Registration Number
4705767
Registration Date
2015-03-24
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2015-01-06
Attorney Name
Law Office Assigned Location Code
L30
Employee Name
GRIFFIN, JAMES
Statements
Goods and Services
Pharmaceutical and veterinary products for treating progression of chronic diseases, proliferative diseases, and for treating rheumatological diseases; pharmaceutical and veterinary products for treating oncological diseases, especially colon cancer, rectum cancer, breast cancer, prostate cancer, pancreatic cancer, gastric cancer, thyroid cancer, larynx cancer, liver cancer, uterine cancer, cervical cancer, esophagus cancer, ovarian cancer, lung cancer, pleural cancer, oral cavity cancer, kidney cancer, bladder cancer, testicular cancer, melanoma, lymphatic cancer, hematopoietic cancer, carcinoma, sarcoma, nervous system cancer, particularly primary tumors; pharmaceutical and veterinary products for treating onco-haematological diseases, especially lymphomas, especially Hodgkin's disease and non-Hodgkin lymphomas, lymphadenopathy, myeloma, especially multiple myeloma, and leukemia; pharmaceutical and veterinary products for treating haematological diseases, especially amyloses, and purpura, especially thrombocytopenic purpura; pills, capsules, tablets, and powders pertaining to healthy diet for use in treating oncological diseases; chemical preparations for medical and pharmaceutical use for treating progression of chronic diseases, proliferative disease, and for treating rheumatological diseases; chemical preparations for medical and pharmaceutical use for treating oncological diseases, especially colon cancer, rectum cancer, breast cancer, prostate cancer, pancreatic cancer, gastric cancer, thyroid cancer, larynx cancer, liver cancer, uterine cancer, cervical cancer, esophagus cancer, ovarian cancer, lung cancer, pleural cancer, oral cavity cancer, kidney cancer, bladder cancer, testicular cancer, melanoma, lymphatic cancer, hematopoietic cancer, carcinoma, sarcoma, nervous system cancer, particularly primary tumors; chemical preparations for medical and pharmaceutical use for treating onco-haematological diseases, especially lymphomas, especially Hodgkin's disease and non-Hodgkin lymphomas, lymphadenopathy, myeloma, especially multiple myeloma, and leukemia; chemical preparations for medical and pharmaceutical use for treating haematological diseases, especially amyloses, and purpura, especially thrombocytopenic purpura
Pseudo Mark
NEO FORDEX
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2021-11-26
Primary Code
005
Correspondences
Name
M. Scott Alprin
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1196519
International Registration Date
2014-01-31
International Publication Date
2014-03-27
International Renewal Date
2024-01-31
Auto Protection Date
2015-09-27
International Status
001 - Request for extension of protection established
International Status Date
2014-03-27
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2014-03-27SN ASSIGNED FOR SECT 66A APPL FROM IB
2014-03-28NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2014-04-01APPLICATION FILING RECEIPT MAILED
2014-04-29ASSIGNED TO EXAMINER
2014-05-01NON-FINAL ACTION WRITTEN
2014-05-02NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2014-05-02REFUSAL PROCESSED BY MPU
2014-05-02NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2014-05-23REFUSAL PROCESSED BY IB
2014-10-31TEAS RESPONSE TO OFFICE ACTION RECEIVED
2014-10-31CORRESPONDENCE RECEIVED IN LAW OFFICE
2014-11-01TEAS/EMAIL CORRESPONDENCE ENTERED
2014-11-04EXAMINERS AMENDMENT -WRITTEN
2014-11-04EXAMINERS AMENDMENT E-MAILED
2014-11-04NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2014-11-04EXAMINER'S AMENDMENT ENTERED
2014-11-04APPROVED FOR PUB - PRINCIPAL REGISTER
2014-11-22ASSIGNED TO LIE
2014-12-01LAW OFFICE PUBLICATION REVIEW COMPLETED
2014-12-17NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2014-12-17NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2014-12-17NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2015-01-03NOTIFICATION PROCESSED BY IB
2015-01-06PUBLISHED FOR OPPOSITION
2015-01-06OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2015-03-24REGISTERED-PRINCIPAL REGISTER
2015-06-06NEW REPRESENTATIVE AT IB RECEIVED
2015-06-24FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2015-07-30FINAL DISPOSITION PROCESSED
2015-07-30FINAL DISPOSITION NOTICE SENT TO IB
2015-09-18FINAL DECISION TRANSACTION PROCESSED BY IB
2019-11-15NEW REPRESENTATIVE AT IB RECEIVED
2020-03-24COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
2020-05-07NEW REPRESENTATIVE AT IB RECEIVED
2021-11-26CANCELLED SECTION 71